ES442217A1 - Procedimiento para la obtencion de derivados cefem. - Google Patents

Procedimiento para la obtencion de derivados cefem.

Info

Publication number
ES442217A1
ES442217A1 ES442217A ES442217A ES442217A1 ES 442217 A1 ES442217 A1 ES 442217A1 ES 442217 A ES442217 A ES 442217A ES 442217 A ES442217 A ES 442217A ES 442217 A1 ES442217 A1 ES 442217A1
Authority
ES
Spain
Prior art keywords
methyl
dihydro
oxo
thiadiazolyl
pyridylacetamido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES442217A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2345402A external-priority patent/DE2345402C3/de
Priority claimed from DE19742427224 external-priority patent/DE2427224A1/de
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES442217A1 publication Critical patent/ES442217A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ES442217A 1973-09-08 1975-10-30 Procedimiento para la obtencion de derivados cefem. Expired ES442217A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2345402A DE2345402C3 (de) 1973-09-08 1973-09-08 7-( 1 ^-DihydnM-oxo-1 -pyridylacetamido)-cephemderivate und Verfahren zu ihrer Herstellung
DE19742427224 DE2427224A1 (de) 1974-06-06 1974-06-06 Cephemderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES442217A1 true ES442217A1 (es) 1977-07-01

Family

ID=25765762

Family Applications (2)

Application Number Title Priority Date Filing Date
ES429864A Expired ES429864A1 (es) 1973-09-08 1974-09-07 Procedimiento para la obtencion de derivados cefem.
ES442217A Expired ES442217A1 (es) 1973-09-08 1975-10-30 Procedimiento para la obtencion de derivados cefem.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES429864A Expired ES429864A1 (es) 1973-09-08 1974-09-07 Procedimiento para la obtencion de derivados cefem.

Country Status (21)

Country Link
US (1) US4153693A (es)
JP (2) JPS551274B2 (es)
AR (3) AR205799A1 (es)
CA (1) CA1072542A (es)
CH (2) CH605992A5 (es)
CY (1) CY970A (es)
DD (1) DD114268A5 (es)
DK (1) DK473974A (es)
EG (1) EG11821A (es)
ES (2) ES429864A1 (es)
FR (1) FR2242987B1 (es)
GB (1) GB1436989A (es)
HK (1) HK62878A (es)
IL (1) IL45488A (es)
IT (1) IT1106059B (es)
KE (1) KE2890A (es)
MY (1) MY7800442A (es)
NL (1) NL7411868A (es)
NO (1) NO147754C (es)
SE (1) SE433850B (es)
YU (1) YU36182B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2507834A1 (de) * 1975-02-24 1976-09-02 Merck Patent Gmbh Cephemderivate und verfahren zu ihrer herstellung
JPS55153791A (en) * 1979-05-18 1980-11-29 Sumitomo Chem Co Ltd Novel beta-lactam compound
KR100841044B1 (ko) * 2002-01-15 2008-06-25 주식회사 엔지켐 세팔로스포린 화합물의 제조 방법
CN101584671B (zh) * 2009-07-17 2011-03-16 山东罗欣药业股份有限公司 一种头孢西酮钠药物粉针剂以及头孢西酮钠原料药的合成方法
CN104119361B (zh) * 2014-07-10 2015-07-29 山东罗欣药业集团股份有限公司 一种新型抗生素化合物的精制方法
CN104230958A (zh) * 2014-08-22 2014-12-24 赵明亮 一种头孢西酮的制备方法
CN106967092B (zh) * 2017-04-12 2019-05-03 山东裕欣药业有限公司 一种头孢西酮的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3218318A (en) * 1962-08-31 1965-11-16 Lilly Co Eli 7-heterocyclic-substituted-acylamido cephalosporins
US3833570A (en) * 1970-08-12 1974-09-03 Bristol Myers Co 7-(3-substituted-1,2,4-oxadiazole-5-one-4-acetamido)cephalosporanic acids and derivatives thereof
US3956288A (en) * 1973-11-07 1976-05-11 Richardson-Merrell Inc. 7-[(2,4-Dioxo-1-pyrimidinyl)acylamino]cephalosporin derivatives
US3956287A (en) * 1973-11-07 1976-05-11 Richardson-Merrell Inc. 7-[(2-Oxo-1-pyridinyl)acylamino]cephalosporin derivatives
US4119775A (en) * 1974-09-27 1978-10-10 Richardson-Merrell Inc. 4-Oxo-1-pyridinyl cephalosporin derivatives

Also Published As

Publication number Publication date
EG11821A (en) 1977-12-31
NO147754B (no) 1983-02-28
NO743205L (es) 1975-04-07
CH605992A5 (es) 1978-10-13
IT7851703A0 (it) 1978-10-30
IL45488A0 (en) 1974-11-29
IT1106059B (it) 1985-11-11
CA1072542A (en) 1980-02-26
MY7800442A (en) 1978-12-31
YU36182B (en) 1982-02-25
KE2890A (en) 1978-10-27
JPS614833B2 (es) 1986-02-13
FR2242987A1 (es) 1975-04-04
ES429864A1 (es) 1977-01-01
IL45488A (en) 1977-10-31
US4153693A (en) 1979-05-08
JPS5253866A (en) 1977-04-30
AR208079A1 (es) 1976-11-30
AU7243474A (en) 1976-02-19
AR202261A1 (es) 1975-05-23
JPS551274B2 (es) 1980-01-12
HK62878A (en) 1978-11-03
AR205799A1 (es) 1976-06-07
JPS5053392A (es) 1975-05-12
DD114268A5 (es) 1975-07-20
NO147754C (no) 1983-06-08
DK473974A (es) 1975-05-05
SE433850B (sv) 1984-06-18
CY970A (en) 1978-12-22
FR2242987B1 (es) 1977-11-04
NL7411868A (nl) 1975-03-11
YU240474A (en) 1981-06-30
GB1436989A (en) 1976-05-26
CH605993A5 (es) 1978-10-13
SE7411162L (es) 1975-03-10

Similar Documents

Publication Publication Date Title
ES8202546A1 (es) Metodo de producir derivados de tiazolidina
ES8104233A1 (es) Procedimiento para preparar derivados de acidos quinolina- carboxilicos
ES8704955A1 (es) Un proceso para la produccion de un compuesto de cefalospo- rina
IE45015L (en) Cephalosporin derivatives.
IE43840L (en) Clavulanic acid derivatives
DE69032681D1 (de) Cephalosporine und ihre Homologen, Verfahren zu ihrer Herstellung und pharmazeutische Präparate
GB1509500A (en) Cephalosporin derivatives
ES429864A1 (es) Procedimiento para la obtencion de derivados cefem.
IE40335B1 (en) Pyrazole derivatives, process for their preparation and their use as medicaments
ES456499A1 (es) Procedimiento para producir derivados cefalosporinicos.
ES462012A1 (es) Un procedimiento para preparar derivados de cefalosporinas.
ES442057A1 (es) Procedimiento para la obtencion de penicilinas.
IE45559L (en) ß-LACTAM COMPOUNDS
GB1277415A (en) Improvements in or relating to cephalosporin derivatives
CA1268183A (en) INTERMEDIATES OF PHOSPHORANE USED IN THE PREPARATION OF ANTIBIOTIC PENEMS
ES8507151A1 (es) Un metodo de producir derivados de cefalosporina
IE43346L (en) Cephalosporin derivatives.
GB1464330A (en) Cephalosporin esters with antibacterial activity
IE820238L (en) Carbapenem derivatives
GB1508071A (en) Cephalosporins and process for producing the same
ES8307819A1 (es) "un metodo de producir derivados de cefalosporina".
GB1512130A (en) Cephalosporin derivatives
IE44999L (en) Hydrazinopyridazine derivatives.
IE44029L (en) Cephalosporin derivatives.
ES476259A1 (es) Un procedimiento para la preparacion de un compuesto.